Hormone therapy (HT) uses one or more hormones to treat symptoms of menopause. HT uses estrogen, progestin (a type of progesterone), or both. Sometimes testosterone is also added.
Menopause symptoms include:
After menopause, your body stops making estrogen and progesterone. HT can treat menopause symptoms that bother you.
HT does have some risks. It may increase your risk for:
Despite these concerns, for many women, HT is a safe way to treat menopause symptoms, as long as you take it:
HT comes in different forms. You may need to try different types before finding one that works best for you.
Estrogen comes in:
Most women who take estrogen and who still have their uterus also need to take progestin. Taking both hormones together lowers the risk of endometrial (uterine) cancer. Women who have had their uterus removed can't get endometrial cancer. So estrogen alone is recommended for them.
Progesterone or progestin comes in:
The type of HT your doctor prescribes may depend on what menopause symptoms you have. For example, pills or patches can treat night sweats. Vaginal rings, creams, or tablets help relieve vaginal dryness.
When taking estrogen and progesterone together, your doctor may suggest one of the following schedules:
Cyclic hormone therapy is often recommended when you start menopause.
Combined therapy is when you take estrogen and progestin together every day.
Your doctor may prescribe other medicines if you have severe symptoms or have a high risk of osteoporosis. For example, you may also take testosterone, a male hormone, to improve your sex drive.
HT can have side effects, including:
Tell your doctor if you notice side effects. Changing the dose or type of HT you take may help reduce these side effects. Don’t change your dose or stop taking HT before talking with your doctor.
If you have vaginal bleeding or other unusual symptoms during hormone therapy, call your doctor.
Be sure to continue seeing your doctor for regular checkups when taking hormone therapy.
HRT; Estrogen replacement therapy; ERT; Hormone replacement therapy
American College of Obstetricians and Gynecologists. Hormone therapy and heart disease. Committee Opinion No. 565. Obstet Gynecol. 2013;121:1407-10.
Davis SR, Davidson SL. Current perspectives on testosterone therapy for women. Menopausal Medicine. 2012;20(2).
Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause: The Journal of The North American Menopause Society. 2010;17:25-54; quiz 55-56.
National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. 2013. http://nof.org/files/nof/public/content/file/2157/upload/872.pdf. Accessed October 29, 2013.
North American Menopause Society. Position Statement: The 2012 Hormone Therapy Position Statement of The North American Menopause Society. Menopause: The Journal of The North American Menopause Society. 2012; 19 (3): 257-271.
Updated by: Susan Storck, MD, FACOG, Chief, Eastside Department of Obstetrics and Gynecology, Group Health Cooperative of Puget Sound, Bellevue, Washington; Clinical Teaching Faculty, Department of Obstetrics and Gynecology, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2015, A.D.A.M., Inc. Duplication for commercial use must be authorized in writing by ADAM Health Solutions.